Μπορείτε να στέλνετε ειδήσεις και Δελτία Τύπου στο email μας.
Αν θέλετε να επικοινωνήσετε μαζί μας ή να στείλετε Δελτίο Τύπου πατήστε εδώ...pharmamarketingexpertsblog@gmail.com


Κυριακή 28 Φεβρουαρίου 2016

Native advertising for pharma: Winning format or slippery slope to regulatory headaches?






FiercePharmaMarketing  | By Beth Snyder Bulik



Did you see that ad? In many cases of native advertising, the answer is no--because people can't always tell what's an ad and what isn't. A study in the December Journal of Advertising found that the majority of consumers can't tell the difference between native advertising and editorial content. As more pharma marketers begin to embrace the format, and as the Federal Trade Commission continues to home in on native advertising for any deceptive practices, the findings are worth noting.
In two different experiments, researchers from Grady College in Georgia found surprisingly low recognition of advertising. In the first, consumers were asked to read two stories, one that was native advertising and the other editorial. The native ads were marked with a variety of labels including "sponsored content," "advertisement," and "presented by" placed in different areas around the page. Overall, fewer than 8%--17 people out of 242--recognized the native advertising as an ad.